Canfite earnings
WebEarnings estimates and surprises for Can-Fite Biopharma Ltd ADR (CANF) are an important tool used to evaluate the company's overall strength and value of the stock. … WebThe Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from …
Canfite earnings
Did you know?
WebEarnings Estimates are available only for US equities. >Earnings Surprises. The first table on the Estimates page compares Actual vs. Estimated earnings for the last four … WebMar 30, 2024 · Can-Fite Biopharma Ltd ADR (CANF) reported a 4th Quarter December 2024 loss of $1.11 per share on revenue of $0.2 million. The consensus estimate was a loss of $0.57 per share on revenue of $0.3 million. Revenue fell 3.4% compared to the same quarter a year ago.
WebApr 10, 2024 · View differences made from one to another to evaluate Canfite Biopharma Ltd.'s financial trajectory Sample 10-K Year-over-Year (YoY) Comparison Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Canfite Biopharma Ltd.. WebMar 13, 2024 · [email protected] +972-3-9241114 View source version on businesswire.com: https: ... 5 Things for All Investors to Watch in Q1 Bank Earnings Sandy Ward 1 days ago Market Update ...
WebApr 6, 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Can-Fite BioPharma stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for CANF. The average twelve-month price prediction for Can-Fite BioPharma is $34.00 with a high price target of $34.00 and a low price target of $34.00. WebIn fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns …
WebCan-Fite Biopharma Ltd. ADR analyst estimates, including CANF earnings per share estimates and analyst recommendations.
WebMar 5, 2024 · Earnings Estimate Revisions for CanFite Biopharma Ltd For the fiscal year ending December 2024, this company is expected to earn -$1.26 per share, which is a … cider house rules movie wikiWebApr 10, 2024 · -- Can-Fite Biopharma Ltd teilte am Montag mit, dass es vom Ausschuss für Humanarzneimittel der Europäischen Arzneimittelagentur eine positive Stellungnahme zu seinem Zulassungsplan für eine... 11 April 2024 cider house rules charactersWebIn fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according ... dhaka rain forecastWebApr 10, 2024 · Can-Fite BioPharma Ltd. gab bekannt, dass das Unternehmen vom Ausschuss für Humanarzneimittel der Europäischen Arzneimittelagentur eine positive Stellungnahme zur Einreichung eines... 11 April 2024 cider house poulsboWebMar 30, 2024 · Can-Fite BioPharma Ltd. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.81 million compared to USD 0.853 million a year ago. Net loss was USD 10.17 million compared to USD 12.62 million a year ago. cider house rules john irvingWebCan Fite is trading at 3.24 as of the 14th of February 2024. This is a -6.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.0. Stay informed regarding Can Fite Stock and understand the value of trading Can Fite now. Get the latest Can Fite detailed stock quotes, stock trade data, stock price info, and performance … ciderhouse settlementWebNov 21, 2011 · Can-Fite BioPharma General Information. Description. Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. cider house rules oscar winner